Effect of polyfluorinated compounds exposure and PPAR alpha pathway polymorphisms on maternal BMI and lipid profile, birth weight, growth and development of infants in Japan
Effect of polyfluorinated compounds exposure and PPAR alpha pathway polymorphisms on maternal BMI and lipid profile, birth weight, growth and development of infants in Japan
批准号:
25893004
负责人:
GOUDARZI Houman
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Research Activity Start-up
财政年份:
2013
资助国家:
日本
项目状态:
已结题
起止时间:
2013-08-30 至 2015-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This study is a part of "The Hokkaido Study on Environment and Children's Health" as a prospective birth cohort. In this study, our objective is to evaluate the epidemiological effect of maternal PFCs exposure and peroxisome proliferator activating-receptors pathway polymorphisms on maternal lipid profile, birth outcome (birth weight, birth size), and children’s growth until school age.Prenatal levels of PFC compounds including PFOA and PFOS are available in maternal serum samples (n=514) between 2002 and 2005. Concentration of these chemicals were measured by liquid chromatography tandem mass spectrometry (LC-MS/MS). Primers for SNPs determination of following gens were purchased: PPARs (α, β, and γ), Leptin, LXR, HNF4α, and CAR. 400 μl of maternal whole blood samples which are collected immediately after delivery were subjected to the genomic DNA extraction. Using EP1 system (Fluidigm), I am examining SNP genotyping by end-point reading after PCR method. This process will be finished until 2014, September. After finishing genetic analysis, we assess the effect of prenatal PFCs exposure in underlying genetic background (SNPs in PPAR and PPAR-related pathways) on maternal TG and fatty acids during pregnancy. It may result in low birth size, and birth weight. Also, we are going to observe longitudinal effects of these chemical and genetic factors on child’s growth until school age. Therefore, we can identify of high risk groups classified by genetic susceptibility to PFCs exposure as a novel national pattern of environment-genetic interaction in Japanese population.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
環境健康科学研究教育センター 研究業績
环境健康科学研究与教育中心研究成果
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
環境と健康ひろば
环境健康广场
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Effects of prenatal perfluorinated chemicals exposure and genetic vulnerability on glucocorticoids hormone profiles, growth and risk of infectious diseases in next generation
-
批准号:26740028
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2014
-
负责人:GOUDARZI Houman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
稳定期COPD中医证型的脂代谢紊乱特征及PPARγ/CPT1A调控机制及临床研究
-
批准号:JCZRLH202601649
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“郁痰”理论探讨海藻消瘤胶囊调控ERα-PPARγ轴抑制PTC细胞代谢失衡的作用机制
-
批准号:JCZRLH202601582
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IPA靶向FABP4/PPARγ信号通路改善肥胖相关性肾小球疾病
-
批准号:2026JJ81107
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺超
-
依托单位:
M2巨噬细胞外泌体通过MEG3/PPARγ/Nrf2轴介导铁死亡抑制子痫前期进展的作用及机制研究
-
批准号:2026JJ50641
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:喻玲
-
依托单位:
基于PPARα—肠道菌群—代谢物探讨非诺贝特改善高尿酸血症性肾病的作用及机制研究
-
批准号:2026JJ60065
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李璐
-
依托单位:
GPER激活通过PPARγ抑制小胶质细胞脂滴累积缓解绝经期抑郁
-
批准号:2026JJ82277
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈亮
-
依托单位:
BMP4 p.H251Y突变抑制巨噬细胞PPARγ-LXRα-ABCA1/G1通路导致青年冠心病的机制研究
-
批准号:JCZRLH202601083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
涤痰益智汤通过PPARα/PGC-1α/PDK4信号轴重塑线粒体能量代谢稳态治疗血管性痴呆的机制研究
-
批准号:JCZRLH202601058
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
蒲公英甾醇通过 PPAR 通路调控巨噬细胞 M2极化减轻肝细胞凋亡抑制高毒力肺炎克雷伯菌致肝脓肿形成的机制研究
-
批准号:ZCLMS26H2002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙瑶
-
依托单位:
基于PPARγ/PGC1α信号通路探究Alox15在阿霉素诱导心肌病中的作用与潜在机制
-
批准号:JCZRQNB202600846
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: